Literature DB >> 11276398

New developments in mechanisms of obesity-induced hypertension: role of adipose tissue.

A M Sharma1, S Engeli, T Pischon.   

Abstract

Hypertension develops in almost 60% of obese individuals. Apart from the recent observation of obesity-associated structural changes in kidney structure that may lead to enhanced tubular sodium reabsorbtion, reports of paracrine and hormonal factors derived from adipose tissue have prompted speculations about the role of adipose tissue in the pathophysiology of obesity-induced hypertension. We summarize recent data on leptin's sympathoexcitatory actions, the possible influence of adipose tissue on atrial natriuretic peptide levels, and the formation of vasoactive substances, such as angiotensin II and nonesterified fatty acids, by adipocytes. The mechanisms discussed herein may contribute to the typical findings in obesity-induced hypertension, including volume expansion, sodium retention, enhanced sympathetic nervous system activity, increased activity of the systemic renin-angiotensin system, low atrial natriuretic peptide levels, and disturbed glucose and insulin metabolism. Together, these data strengthen the hypothesis that adipose tissue is potentially a major regulator of cardiovascular-renal function.

Entities:  

Mesh:

Year:  2001        PMID: 11276398     DOI: 10.1007/s11906-001-0030-x

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  48 in total

1.  Weight gain-induced blood pressure elevation.

Authors:  K Masuo; H Mikami; T Ogihara; M L Tuck
Journal:  Hypertension       Date:  2000-05       Impact factor: 10.190

2.  Plasma leptin concentrations and cardiac autonomic nervous system in healthy subjects with different body weights.

Authors:  G Paolisso; D Manzella; N Montano; A Gambardella; M Varricchio
Journal:  J Clin Endocrinol Metab       Date:  2000-05       Impact factor: 5.958

3.  Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation.

Authors:  H O Steinberg; M Tarshoby; R Monestel; G Hook; J Cronin; A Johnson; B Bayazeed; A D Baron
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

4.  Gene expression of angiotensinogen in adipose tissue of obese patients.

Authors:  G Giacchetti; E Faloia; C Sardu; M A Camilloni; B Mariniello; C Gatti; G G Garrapa; M Guerrieri; F Mantero
Journal:  Int J Obes Relat Metab Disord       Date:  2000-06

5.  Comparative analysis of atrial natriuretic peptide receptor expression in rat tissues.

Authors:  R Sarzani; V M Paci; P Dessì-Fulgheri; E Espinosa; A Rappelli
Journal:  J Hypertens Suppl       Date:  1993-12

6.  Chronic leptin infusion increases arterial pressure.

Authors:  E W Shek; M W Brands; J E Hall
Journal:  Hypertension       Date:  1998-01       Impact factor: 10.190

7.  Distribution of renal medullary hyaluronan in lean and obese rabbits.

Authors:  T M Dwyer; S A Banks; M Alonso-Galicia; K Cockrell; J F Carroll; S A Bigler; J E Hall
Journal:  Kidney Int       Date:  2000-08       Impact factor: 10.612

8.  Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis [seecomments].

Authors:  G Wolf; A Hamann; D C Han; U Helmchen; F Thaiss; F N Ziyadeh; R A Stahl
Journal:  Kidney Int       Date:  1999-09       Impact factor: 10.612

9.  Renal denervation prevents and reverses hyperinsulinemia-induced hypertension in rats.

Authors:  W C Huang; T C Fang; J T Cheng
Journal:  Hypertension       Date:  1998-08       Impact factor: 10.190

10.  Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism.

Authors:  R K Davda; K T Stepniakowski; G Lu; M E Ullian; T L Goodfriend; B M Egan
Journal:  Hypertension       Date:  1995-11       Impact factor: 10.190

View more
  14 in total

Review 1.  Complex interactions in complex traits: obesity and asthma.

Authors:  K G Tantisira; S T Weiss
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

Review 2.  Management of hypertension in overweight and obese patients: a practical guide for clinicians.

Authors:  Francesco Dentali; Arya M Sharma; James D Douketis
Journal:  Curr Hypertens Rep       Date:  2005-10       Impact factor: 5.369

3.  Genetically driven adiposity traits increase the risk of coronary artery disease independent of blood pressure, dyslipidaemia, glycaemic traits.

Authors:  Wan-Qiang Lv; Xue Zhang; Kun Fan; Xin Xia; Qiang Zhang; Hui-Min Liu; Bu-Ying Jiang; Wei-Dong Zhang; Hong-Wen Deng
Journal:  Eur J Hum Genet       Date:  2018-06-11       Impact factor: 4.246

Review 4.  Neuroinflammatory basis of metabolic syndrome.

Authors:  Sudarshana Purkayastha; Dongsheng Cai
Journal:  Mol Metab       Date:  2013-10-05       Impact factor: 7.422

Review 5.  Leptin and mechanisms of endothelial dysfunction and cardiovascular disease.

Authors:  Jarrod D Knudson; Gregory A Payne; Léna Borbouse; Johnathan D Tune
Journal:  Curr Hypertens Rep       Date:  2008-12       Impact factor: 5.369

Review 6.  Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative review.

Authors:  Andrew S Bomback; Philip J Klemmer
Journal:  Am J Nephrol       Date:  2009-03-20       Impact factor: 3.754

7.  Blood pressure control and weight loss in overweight or obese patients with previously treated or untreated mild to moderate hypertension given valsartan: An open-label study comparing pretreatment and posttreatment values.

Authors:  Aldo S Villecco; Cinzia Cocci; Maurizio Di Emidio
Journal:  Curr Ther Res Clin Exp       Date:  2004-03

8.  Factors associated with the prevalence of hypertension in the southeastern United States: insights from 69,211 blacks and whites in the Southern Community Cohort Study.

Authors:  Uchechukwu K A Sampson; Todd L Edwards; Eiman Jahangir; Heather Munro; Minaba Wariboko; Mariam G Wassef; Sergio Fazio; George A Mensah; Edmond K Kabagambe; William J Blot; Loren Lipworth
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-12-23

Review 9.  The management of hypertension in the overweight and obese patient: is weight reduction sufficient?

Authors:  James D Douketis; Arya M Sharma
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  The Factors Affecting Lower Urinary Tract Functions in Patients Undergoing Laparoscopic Sleeve Gastrectomy.

Authors:  Haci Murat Cayci; Sedat Oner; Umut Eren Erdogdu; İdris Nas; Evren Dilektasli; Murat Demirbas
Journal:  Obes Surg       Date:  2018-04       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.